Psychoactive Substances Update: Kratom, Cannabinoids, Fentanyl & More
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Psychoactive Substances Update: Kratom, Cannabinoids, Fentanyl & More
Recorded: Thursday, April 22, 2021 - Saturday, April 24, 2021
This 1-hour on-demand session from ASAM Virtual 2021 addresses emerging psychoactive drugs such as kratom, synthetic cannabinoids, nonpharmaceutical fentanyls, gabapentin, and others as well as their clinical issues, detection problems, and treatment options.
New psychoactive drugs can be challenging to identify and treat, especially serious medical and psychiatric complications. This is important, as new designer drugs have resulted in multiple deaths and significant health consequences. This session will inform attendees about emerging psychoactive drugs, including kratom, synthetic cannabinoids, nonpharmaceutical fentanyls, gabapentin, and others. The presentation will be evidence-based and draw from existing medical literature, and will also include the panelists’ clinical experience. The emphasis will be on clinical issues, especially recognition of intoxication, problems related to detection with urine drug testing, and treatment of medical and psychiatric complications. Time will be allowed for questions to the panelists.
The target audience for this beginner level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Patient Care, Medical Knowledge.
Upon completion, learners will be able to:
- Identify emerging psychoactive substances, including kratom, synthetic cannabinoids, nonpharmaceutical fentanyls, gabapentin, and others
- Recognize clinical clues to intoxication with emerging natural and synthetic substances, and ways to differentiate from other drug use
- Discuss treatment of medical and psychiatric complications resulting from use of emerging substances of abuse
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to firstname.lastname@example.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 04/30/2024
- Click the Contents tab and select "View On-Demand Recording". After viewing the entire video, return to the Contents tab.
- Click "Complete Post Test" to answer quiz questions. You will have 10 attempts and must get at least 2 out of 3 questions correct. After completing the quiz, return to the Contents tab.
- Click Complete Evaluation to answer evaluation questions. Scroll down on all questions, there are answers that expand past the size of the window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).
- Click the button “Claim Credits” in the box titled “Claim Credits & Certificate." Choose the type of credit and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).
If you have are experiencing any log in issues, cannot access a course, need assistance claiming credit, or have other questions or concerns, please e-mail Education@asam.org for assistance.
For learners who may have difficulty typing, moving a mouse or reading, Essential Accessibility is an application available for use to assist.
Michael Weaver, MD, DFASAM is a Professor in the Department of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addiction (CNRA) at the McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth). He received his M.D. degree from Northeast Ohio Medical University, and completed Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University (VCU) Health System, and he is Board-certified in Internal Medicine through the American Board of Internal Medicine and certified in Addiction Medicine through the American Board of Preventive Medicine. Dr. Weaver is the Sub-Board Chair for Addiction Medicine on the American Board of Preventive Medicine, and also serves as the Chair of the Examination Committee for certification in Addiction Medicine. He has been a member of ASAM for over 20 years and has been a member of the Publications Council and the Annual Conference Program Planning Committee. He is currently involved in patient care, medical education, and research. Dr. Weaver sees patients in the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston.
He has extensive experience teaching about addiction to medical students, residents, and community professionals at all levels. He has been involved in multiple research projects, and currently is collaborating with other researchers in the CNRA on studies involving cocaine, methamphetamine, marijuana, and electronic cigarettes. Dr. Weaver has multiple publications in the field of addiction medicine, including the book "Addiction Treatment" published by Carlat Publishing in 2017.
Disclosures- No Disclosures
John A. Hopper
John A. Hopper, MD, FAAP, FACP, DFASAM graduated from the Wayne State University School of Medicine and completed residency training in Combined Internal Medicine and Pediatrics at the University of North Carolina, where he served as Co-Chief Resident in Pediatrics. Dr. Hopper was appointed to the faculty at Wayne State University School of Medicine in 1994 where he served as Associate Program Director for the Med-Peds Residency and Medical Director of the Department of Psychiatry’s Research Division on Substance Abuse. From 2005 to 2008, he was the Chief Medical Officer at Brighton Hospital, the second oldest addiction treatment hospital in the United States.
In addition to his many clinical and teaching awards, Dr. Hopper is an author for many publications, and serves on the Editorial Board of the Journal of Opioid Management. From 2008 to 2015 Dr. Hopper directed the Internal Medicine Residency Program at St. Joseph Mercy Hospital in Ann Arbor, Michigan, where he continues to serve as a clinical faculty member. In 2013 Dr. Hopper started Michigan’s only American Board of Addiction Medicine approved addiction fellowship, which he directed until 2015. From 2015 to 2020, Dr. Hopper was a Field Reviewer for the Clinical Learning Environment Review Program of the Accreditation Council on Graduate Medical Education. Dr. Hopper currently serves as Medical Director of the Chemical Dependency Unit at St. Mary Mercy Hospital in Livonia, Michigan. He is Associate Program Director of the Addiction Medicine Fellowship at St. Joseph Mercy Hosptial in Ann Arbor, Michigan.
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Physician Assistants
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 5/26/2021 to 5/26/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202755.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222.
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
American Board of Medical Specialties (ABMS)
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, The ASAM Virtual.2021 has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Allergy and Immunology, Anesthesiology, Colon and Rectal Surgery, Family Medicine, Medical Genetics and Genomics, Nuclear Medicine, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry and Neurology, Radiology, Thoracic Surgery, Urology
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 credit towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) Tmoc credit requirements.
Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits.
CME Committee, Program Planning Committee, and Faculty Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
|Access Date||Quiz Result||Score||Actions|